Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
sna
Press Release
Aug 13, 2020
Safety NetAccess, Inc. Creates 'HomeWorx' Product to Help Companies Manage the Work From Home Movement
Read More
Press Release
Jul 8, 2020
Safety NetAccess, Inc. Creates SNA Event Productions Division, Appoints Martin Kwitschau Division President
Read More
Press Release
Nov 13, 2018
Safety NetAccess, Inc. Establishes Resale Agreement With Phonesuite
Read More
Press Release
Apr 25, 2012
Repligen Reports Positive Results From Phase 1 Clinical Trial for Spinal Muscular Atrophy (SMA).
Repligen Corporation (NASDAQ:RGEN) today announced positive results from a Phase 1 study to evaluate the pharmacokinetic (PK) and safety profile of RG3039, a novel small molecule drug candidate for the potential treatment of SMA.
Read More
First
Prev
1
Next
Last
